Page last updated: 2024-11-04

diisopropyl methylphosphonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diisopropyl methylphosphonate: by-product of sarin manufacture; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diisopropyl methylphosphonate : An organic phosphonate that is the diisopropyl ester of methylphosphonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3073
CHEMBL ID1232236
CHEBI ID77325
SCHEMBL ID472052
MeSH IDM0080761

Synonyms (40)

Synonym
56v3og5dc7 ,
phosphonic acid, p-methyl-, bis(1-methylethyl) ester
4-04-00-03501 (beilstein handbook reference)
unii-56v3og5dc7
CHEMBL1232236
chebi:77325 ,
einecs 215-896-0
brn 1761635
hsdb 6864
bis(1-methylethyl) methylphosphonate
phosphonic acid, methyl-, diisopropyl ester
phosphonic acid, methyl-, bis(1-methylethyl) ester
diisopropyl methanephosphonate
methylphosphonic acid bis(1-methylethyl)ester
DB02127
methylphosphonic acid diisopropyl ester
diisopropyl methylphosphonate
1445-75-6
2-[methyl(propan-2-yloxy)phosphoryl]oxypropane
NCGC00248074-01
NCGC00254262-01
tox21_201712
cas-1445-75-6
NCGC00259261-01
tox21_300474
dtxsid5024051 ,
dtxcid304051
AKOS006229159
FT-0624992
SCHEMBL472052
WOAFDHWYKSOANX-UHFFFAOYSA-N
phosphonic acid, methyl-, o,o-bis-isopropyl ester
dimp (phosphonate)
o,o-diisopropyl methylphosphonate
phosphonic acid,p-methyl-, bis(1-methylethyl) ester
mfcd00015022
J-007969
Q5276479
methyl-phosphonic acid diisopropyl ester
phosphonic acid,p-methyl-,bis(1-methylethyl)ester

Research Excerpts

Effects

ExcerptReferenceRelevance
"Diisopropyl methylphosphonate (DIMP) has been identified as a groundwater contaminant on or near sites of former chemical warfare production facilities. "( Dermal penetration of 14C-labeled diisopropyl methylphosphonate in swine.
Metker, LM; Snodgrass, HL, 1992
)
2.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic phosphonate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency63.31250.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency62.26380.002541.796015,848.9004AID1347395; AID1347398
AR proteinHomo sapiens (human)Potency54.48270.000221.22318,912.5098AID1259243
progesterone receptorHomo sapiens (human)Potency1.72290.000417.946075.1148AID1346784
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency17.22890.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency12.31030.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency25.07890.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.30600.000229.305416,493.5996AID1259244
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency27.30600.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency27.30600.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (17.24)18.7374
1990's9 (31.03)18.2507
2000's10 (34.48)29.6817
2010's4 (13.79)24.3611
2020's1 (3.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.81 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.23%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]